# The Absorption, Metabolism and Excretion of [14C]SH-1028 in Chinese Healthy Male Volunteers

> **NCT04810533** · PHASE1 · COMPLETED · sponsor: **Nanjing Sanhome Pharmaceutical, Co., Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Healthy Male Volunteers

## Interventions

- **DRUG:** [14C] SH-1028

## Key facts

- **NCT ID:** NCT04810533
- **Lead sponsor:** Nanjing Sanhome Pharmaceutical, Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-13
- **Primary completion:** 2021-03-05
- **Final completion:** 2021-03-05
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2021-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04810533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04810533, "The Absorption, Metabolism and Excretion of [14C]SH-1028 in Chinese Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04810533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*